#DHCR7
Compartmentalization of DHCR7 links 7-DHC metabolism to B-ring unsaturated steroid synthesis in the equine fetal gonad. Read more in #Endocrinology: https://bit.ly/4AO3cEA #DHCR7@endocrinesociety.bsky.social
Compartmentalization of DHCR7 links 7-DHC metabolism to B-ring unsaturated steroid synthesis in the equine fetal gonad
Abstract. The endocrinology of equine pregnancy is unique, but many of its unusual phenomena closely resemble pregnancy in women. Placental estrone synthes
bit.ly
October 12, 2026 at 3:18 PM
研究チームは脛骨骨折後に痛みが続くマウスで、脊髄のDHCR7、コレステロール、MCP-3、アストロサイト、細胞内信号を調べました。DHCR7を抑えた後にコレステロールを戻す実験などで、変化の順序を検討しました。
September 14, 2026 at 12:15 PM
Blocking DHCR7 reduced cholesterol buildup, astrocyte responses, and pain sensitivity; adding cholesterol back restored them. The result frames post-fracture pain as a chain from spinal lipid metabolism to immune and glial signaling.
September 14, 2026 at 12:15 PM
After fracture, persistent pain in mice involved spinal DHCR7-dependent cholesterol buildup feeding into the immune signal MCP-3 and astrocyte pathways.

https://doi.org/10.1016/j.neures.2026.105064
#NeuroscienceResearch #Neuroscience #Pain
September 14, 2026 at 12:15 PM
DHCR7を抑えるとコレステロール蓄積、アストロサイトの反応、痛覚過敏が弱まり、コレステロールを戻すと再び強まりました。骨折後慢性痛を、脊髄の脂質代謝からグリア信号へ続く連鎖として捉える結果です。
September 14, 2026 at 12:15 PM
骨折後の痛みが長引くとき、脊髄では脂質代謝も変わっていました。マウスでは、コレステロール合成酵素DHCR7に依存した蓄積が起こり、免疫情報分子MCP-3とアストロサイトの信号を通じて痛みの持続を支えました。

https://doi.org/10.1016/j.neures.2026.105064
#NeuroscienceResearch #Neuroscience #Pain
September 14, 2026 at 12:15 PM
Researchers measured DHCR7, cholesterol, MCP-3, astrocytes, and downstream signaling in mice with lasting pain after tibial fracture. They inhibited the cholesterol-synthesis enzyme and then added cholesterol back to test the order of the pathway.
September 14, 2026 at 12:15 PM
A recent study investigated early changes in ovarian cancer. In this interview Fabian Coscia and Mihnea-Paul Dragomir discuss how the team moved from spatial proteomics discovery to tissue-based validation using an antibody against DHCR7.
www.proteinatlas.org/news/2026-08...
August 13, 2026 at 10:35 AM
The authors included RRIDs in their in Endocrinology paper! Thanks for making your methods matter! #reproducibility #accelerateopenscience #OpenResearch
Compartmentalization of DHCR7 links 7-DHC metabolism to B-ring unsaturated steroid synthesis in the equine fetal gonad
Read the full paper: Compartmentalization of DHCR7 links 7-DHC metabolism to B-ring unsaturated steroid synthesis in the equine fetal gonad
doi.org
August 5, 2026 at 7:01 AM
Feed: "The Journal of Clinical Investigation -- New Articles"
By: Eric S. Peeples, Zeljka Korade, Karoly Mirnics
Sterol biosynthesis, brain development, and disease
Cholesterol biosynthesis is indispensable for CNS development and function. The developing brain relies almost entirely on intrinsic sterol synthesis to support membrane biogenesis, axonal outgrowth, synaptogenesis, and myelination. Pathogenic variants in sterol biosynthetic enzymes, including DHCR7 and DHCR24, result in complex neurodevelopmental disorders such as Smith-Lemli-Opitz syndrome and desmosterolosis. In addition to cholesterol-lowering drugs (statins), some other pharmacological agents such as antipsychotics, antidepressants, and beta blockers can also inhibit cholesterol biosynthesis due to off-target effects. This inhibition produces dual pathophysiological effects: cholesterol depletion and accumulation of its precursor, 7-dehydrocholesterol, an exceptionally oxidizable molecule that spontaneously generates toxic oxysterols. Given the intense demand for cholesterol synthesis in the developing brain, prenatal exposure to sterol biosynthesis–inhibiting medications may have far-reaching effects. In this Review, we describe convergent biochemical, genetic, and epidemiologic data that implicate developmental sterol dysregulation as a modifiable risk factor for neurodevelopmental pathology and underscore the urgent need for routine sterol pathway safety assessment in drug development and prenatal pharmacotherapy.
www.jci.org
July 20, 2026 at 6:49 AM
Así, hace un tiempo elegimos una de ellas para desarrollar un proyecto piloto. La enzima mutada es la 3 beta-hidroxiesteroide-delta 7-reductasa (DHCR7, para los amigos), y causa un síndrome que lleva el nombre de sus descubridores Smith, Lemli y Opitz
January 14, 2025 at 9:35 PM
In today’s #readoftheweek📚, discover how targeting DHCR7 can become a strategy for the treatment of #MetALD and #HCC.

Read this JHEP Reports article: www.jhep-reports.eu/article/S258...

@ucsandiego.bsky.social #LiverSky
June 19, 2025 at 11:53 AM
#gerontology #geriatrics #exposome gene-environment interactions #evolution #health #oncology #metabolism #cholesterol

Individuals with DHCR7 rs12785878
require adequate sunlight prescriptions
to reduce the risk of cancer.
March 22, 2025 at 4:00 AM
DHCR7 Mutation Carriers and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: No Associations According to DecodeME Data — Antoniy Elias Sverdrup et al

#MECFS
Article Link
www.jppn.ru
April 6, 2026 at 1:29 AM
Zu ergänzen wäre, dass die meisten Studien einen U-förmigen Verlauf zeigen: sehr niedrige Spiegel können schlecht sein (bei genetisch bedingtem Mangel, z.B. DHCR7/CYP2R1 z.B. erhöhte Mortalität und Krebsrate, nicht jedoch kardiovaskulär). Erhöhte Spiegel können aber auch schädlich sein.
June 25, 2025 at 12:01 PM
MERUK hilites research using data from DecodeME study. It found no meaningful evidence mutations in DHCR7 gene linked to production & utilisation of cholesterol & vitamin D in body increase risk of ME/CFS. Team suggested cholesterol metab in ppl with ME/CFS deserves closer att
tinyurl.com/aa84jasf
April 17, 2026 at 10:13 AM
RRIDs were included in this paper. RRIDs improve reproducibility in scientific research. #reproducibility #OpenScience #STMpublishing
DHCR7 as a Prognostic and Immunological Biomarker in Human Pan‐Cancer: A Comprehensive Evaluation
doi.org
November 27, 2025 at 8:01 AM
🧵In a previous study from decode genetics we identified a large deficit of homozygosity for DHCR7 c.964-1G>C variant and we also observed increased risk of miscarriage in carrier couples.
In the current study among 366 trios studied, one fetus was homozygous for this variant

rdcu.be/em94l
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality
Nature Communications - Genotypes causing pregnancy loss and perinatal mortality are depleted among living individuals and are therefore difficult to find. Here, using genetic data for 1.52 million...
rdcu.be
May 22, 2025 at 1:39 PM
Smith-Lemli-Opitz Sendromu nedir? Tedavisi nasıl yapılır? Belirtileri nelerdir?

Smith-Lemli-Opitz Sendromu (SLOS), nadir görülen genetik bir metabolik ve gelişimsel bozukluktur. DHCR7 genindeki mutasyon sonucu vücudun kolesterol üretiminde sorun yaşanır. Bu durum hem fiziksel hem de zihinsel…
Smith-Lemli-Opitz Sendromu nedir? Tedavisi nasıl yapılır? Belirtileri nelerdir?
Smith-Lemli-Opitz Sendromu (SLOS), nadir görülen genetik bir metabolik ve gelişimsel bozukluktur. DHCR7 genindeki mutasyon sonucu vücudun kolesterol üretiminde sorun yaşanır. Bu durum hem fiziksel hem de zihinsel gelişim üzerinde etkiler yaratır. Sendrom, ilk kez 1964 yılında tanımlanmış olup otozomal resesif şekilde kalıtılır. SMITH-LEMLI-OPITZ SENDROMU BELİRTİLERİ Belirtiler kişiden kişiye farklılık gösterebilir. Hafif vakalarda sadece öğrenme güçlüğü görülebilirken, ağır vakalarda çoklu organ anomalileri ortaya çıkabilir.
kocaeligazetem.com
August 29, 2025 at 11:54 AM
DHCR7: from sterol biosynthesis to oncogenic role in colorectal cancer @peerj.bsky.social
DHCR7: from sterol biosynthesis to oncogenic role in colorectal cancer
Objective 7-Dehydrocholesterol reductase (DHCR7) is an enzyme that plays a crucial regulatory role in sterol biosynthesis and has been implicated in tumorigenesis and progression. This study aims to elucidate the biological function of DHCR7 in the pathogenesis of colorectal cancer (CRC). Methods By integrating multi-omics data (including public genomic databases and mass spectrometry data from clinical samples) and establishing in vivo and in vitro experimental systems (encompassing animal models and CRC cell lines with gene overexpression and knockdown), we systematically investigated the functional role of DHCR7 in CRC. A multimodal research strategy combining bioinformatics analysis with molecular biology experiments (Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR), western blotting, immunohistochemistry, etc.), proteomics analysis (liquid chromatography–mass spectrometry), and cellular functional assays (proliferation, apoptosis, migration, and invasion) was employed. Results Elevated levels of sterols were observed in CRC tumor tissues, and high cholesterol levels were found to promote the malignant phenotype of tumor cells. Mass spectrometry revealed that DHCR7 was significantly upregulated in CRC tissues and correlated with poor clinical prognosis. DHCR7 could modulate the cholesterol levels in CRC cells; overexpression of this gene enhanced cell proliferation, inhibited apoptosis, and promoted invasion and migration. Conversely, inhibition of DHCR7 expression abrogated these pro-tumorigenic effects, which was consistent with the inactivation of the PI3K/AKT/mTOR signaling pathway and confirmed by pathway reactivation experiments. DHCR7 deficiency significantly reduced tumorigenicity in vivo. Conclusion DHCR7 regulates the progression of CRC both in vitro and in vivo through the PI3K/AKT/mTOR signaling axis and affects the cholesterol levels in CRC.
dlvr.it
November 20, 2025 at 9:09 PM
Cholesterol’s Role in Cancer Progression and Drug Resistance

Cholesterol's Role in Cancer Progression and Drug Resistance A recent study published in Cell Death & Disease reveals a novel molecular mechanism linking cholesterol metabolism to tumor progression and therapy resistance in thyroid…
Cholesterol’s Role in Cancer Progression and Drug Resistance
Cholesterol's Role in Cancer Progression and Drug Resistance A recent study published in Cell Death & Disease reveals a novel molecular mechanism linking cholesterol metabolism to tumor progression and therapy resistance in thyroid cancer. Researchers found that a decline in the protein RTN3 leads to the stabilization of DHCR7, a key enzyme in cholesterol synthesis. This results in increased intracellular cholesterol, which fuels tumor growth and, critically, induces insensitivity to MEK inhibitors, a class of targeted cancer drugs.
blog.sciencebriefing.com
March 29, 2026 at 5:03 AM
記事の要約:医療従事者向けの医療総合サイトが、急性肝障害の新たな治療標的としてDHCR7を発見したことや、肝臓でのフェロトーシス制御因子の探索による新規治療法の可能性について報告しています。DHCR7阻害剤がマウス肝臓の虚血再灌流障害を抑制することが示され、非アルコール性脂肪肝炎など他の慢性疾患にも有望な効果が期待されています。
March 21, 2024 at 11:44 AM
「医療 サイト ツール」に関する記事です: https://www.qlifepro.com/news/20240321/dhcr7.html
急性肝障害の新規治療標的発見、コレステロール合成経路「DHCR7」阻害-自治医大ほか | QLifePro
自治医科大学は、コレステロール合成経路の最終段階を担う酵素「DHCR7」の阻害がフェロトーシスを強力に抑制する作用があることを新たに発見したと発表した。
www.qlifepro.com
March 21, 2024 at 11:44 AM
Many congratulations to Bok-Soon Lee and Yea-In Park from the Kim lab on another awesome discovery! They found cholesterol enzymes DHCR7/DHCR24 drive colon cancer by generating ROS and activating JNK. This could open new doors for targeting cancer metabolism.
🔗 doi.org/10.1016/j.ca...
#Research
July 14, 2025 at 8:34 PM
ME Research UK:

Research using data from the DecodeME study found no meaningful evidence that mutations in the DHCR7 gene, linked to the production and utilisation of cholesterol and vitamin D in the body, increase the risk of ME/CFS.

Read more: tinyurl.com/5a2xn7z8

#mecfs #pwme #cfs
April 19, 2026 at 8:25 PM